Carregant...
US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma
Jan Bassali, 1 Ian Gopal Gould, 2 James A Kaye, 3 Deirdre Mladsi, 4 Jyotsna Mehta 5 1Global Medical and Scientific Affairs Department , Karyopharm Therapeutics, Newton, MA, 02459, USA; 2Research Health Economy, RTI Health Solutions, Research Triangle Park, NC 27709-2194, USA; 3Epidemiology, RTI H...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2020-06-01
|
| Col·lecció: | ClinicoEconomics and Outcomes Research |
| Matèries: | |
| Accés en línia: | https://www.dovepress.com/us-budget-impact-model-for-selinexor-in-relapsed-or-refractory-multipl-peer-reviewed-article-CEOR |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|